07:47 AM EDT, 08/09/2024 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q2 net loss Friday of $0.05 per diluted share, narrowing from a loss of $0.57 per share a year earlier.

Analysts surveyed by Capital IQ expected a loss of $0.26 per share.

Revenue for the quarter ended June 30 was $186.5 million, compared with $73.3 million a year earlier.

Analysts surveyed by Capital IQ expected $126.1 million.

Legend Biotech's ( LEGN ) shares gained 4% in recent premarket activity.

Price: 59.21, Change: +2.30, Percent Change: +4.04